Rituximab for myasthenia gravis developing after bone marrow transplant

Neurology

Volumn 55, Issue 7, 2000, Pages 1062-1063

  Zaja, Francisco ^a   Russo, D ^a   Fuga, G ^a   Perella, G ^a   Baccarani, M ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOANTIBODY; CORTICOSTEROID; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PYRIDOSTIGMINE; RITUXIMAB;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CASE REPORT; CUSHINGOID SYNDROME; DRUG INDUCED DISEASE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION DISORDER; PRIORITY JOURNAL;

EID: 0034633654     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.7.1062-a     Document Type: Article

References (3)

1. Myasthenia gravis after bone marrow transplantation: A case report
2. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD 20
3. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab